Navigation Links
Microtest Offers Free White Paper: 'Virus Testing for Biological Products: Partnering With a Contract Lab'
Date:10/10/2007

AGAWAM, Mass., Oct. 10 /PRNewswire/ -- Microtest has announced the availability of a free white paper titled: "Virus Testing for Biological Products: Partnering With a Contract Lab."

In manufacturing biological products, there is risk of virus contamination at many levels, from raw materials to processing. This contamination risk means virus testing is required. A proper testing program is essential to ensure the biological product achieves the fastest time to market. By working with a qualified contract laboratory, the best testing strategy can be executed to assure product safety.

In this white paper, Merribeth Morin, Ph.D, Director of Virology at Microtest, reviews the potential sources of contamination, cell bank characterization (virus safety), virus concerns during manufacturing, and ways to effectively partner with a contract testing laboratory.

Download the free white paper, "Virus Testing for Biological Products: Partnering With a Contract Lab," at: http://www.microtestlabs.com/biopaper.

Microtest offers a complete range of pharmaceutical and virology test services. These services can support full in-process and product release testing as well as product stability testing, raw material qualification and assay development/validation.

As a growing provider of fill/finish operations, Microtest has all the systems and procedures in place to fully support all the requirements of the FDA, EMEA and any drug-regulating body in the world. With a problem-solving approach, customer service focus, and technical expertise, Microtest has the ability to help pharmaceutical companies reduce costs and risk, support rapid regulatory approvals, and enjoy reliable, fast, turn-arounds.

For more information, contact Microtest on the Web at http://www.microtestlabs.com, or toll-free at: 1-800-631-1680. Download the f
'/>"/>

SOURCE Microtest
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
2. Ambion Offers Gene Expression Profiling Service
3. CIO Leadership Series: Snap-Ons Moreno offers lessons in IT transformation
4. Ethics Board site offers welcome contrast to state IT mistakes
5. Visions: Preizler offers insurers perspective on healthcare IT
6. Hewlett-Packard exec offers innovative counsel
7. Visions: Wade offers straight talk on e-medical records
8. Midwest offers non-stop flight to North Carolina research park
9. Failure of heart drug offers lessons for drug industry
10. MailFoundry offers new spam protection products
11. Sonic Foundry offers Mediasite to military families

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...stCall/ -- Dendreon Corporation (Nasdaq: DNDN ) t...tration (FDA) provided written acknowledgement tha...ion (BLA) for PROVENGE® (sipuleucel-T) is a c...tion Drug User Fee Act (PDUFA) date of May 1, 2010...ded BLA. Dendreon is seeking licensure for PROVEN...
(Date:11/20/2009)...ently announced that a free webinar, “Roller...rticle Characterization”, will be presented ...tion of in situ particle characterization is demon...ies of roller compaction runs while varying raw ma... , (PRWEB) November 20, 2...
(Date:11/19/2009)...tCall/ -- Omeros Corporation (Nasdaq: OMER ) toda...ird quarter ended September 30, 2009. For the thre... a net loss of $3.9 million, or $1.34 per share, a... per share, for the same period in 2008. For the n...eported a net loss of $15.5 million, or $5.29 per ...
(Date:11/19/2009)...e-FirstCall/ -- Spherix Incorporated (Nasdaq: SPE...erapy, and a provider of technical and regulatory ...logy and pharmaceutical companies, today announced...olders. ,, At the meeting, shareholders of Sphe...owing members to the Board of Directors: ,, Do...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4
...Inc. (Nasdaq: CVTX ) announced today that it has ... Medicines Agency (EMEA) for ranolazine for,the tr...European Union (EU),member states. This approval f...for Medicinal Products for Human Use (CHMP) on Apr...urope as add-on therapy for the,symptomatic treatm...
... in Treatment of Heart Failure ...y 10 Bioheart, Inc.,(Nasdaq: BHRT ), a company c...logics that help monitor, diagnose and treat heart...ced it has secured worldwide,non-exclusive distrib...nitor, an interactive and simple-to-use at-home in...
...l/ -- Yongye Biotechnology,International, Inc. ("Y...),a leading distributor of plant and animal nutrie... it has engaged MSPC Certified Public,Accountants ...ditor., The Company has engaged MSPC Certified Pu...ve as the Company,s independent auditor effective,...
Other Biology Technology:CV Therapeutics Receives European Marketing Authorization for Ranolazine for the Treatment of Patients With Chronic Angina 2CV Therapeutics Receives European Marketing Authorization for Ranolazine for the Treatment of Patients With Chronic Angina 3Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients 2Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients 3Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients 4Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients 5Yongye Biotechnology International, Inc. Appoints New Independent Auditor 2
(Date:11/20/2009)...esearchers are invited to contribute their abstrac... WCO ECCEO10), the largest global meeting devoted... research and patient care. The Congress will be h...inning today, abstracts can be submitted online at...on deadline is February 4, 2010. , IOF and ESCEO...
(Date:11/20/2009)... , Toxic dust: Toxins in coal-tar-based sealcoa...ted house dust, according to a USGS study. PAHs ...ecules found in oil, coal and tar deposits, and ca...Hs are often found in house dust; however, the spe...ed. Researchers found that dust from indoor areas ...
(Date:11/20/2009)...urplus biomass from the production of flax shives,...flowered plant related to those which engulf field...is has been suggested by two studies carried out b...he journal Renewable and Sustainable Energy Revie...ntal point of view, the production of bioethanol f...
Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Flax and yellow flowers can produce bioethanol 2Wounded Warrior Project 28WWP 29 Seeks to Provide Mind Body and Spirit Healing for Combat Stress 50652 1Wounded Warrior Project 28WWP 29 Seeks to Provide Mind Body and Spirit Healing for Combat Stress 50652 2Pennsylvania DEP Lehigh Valley Berks County Air Quality Partnership Urge Public Transit Use 50648 1Pennsylvania DEP Lehigh Valley Berks County Air Quality Partnership Urge Public Transit Use 50648 2Extreme Heat Causes Major Health Problems for Older Adults 50644 1Extreme Heat Causes Major Health Problems for Older Adults 50644 2
...of photosynthesizing microbes in prehistoric rocks...pplied innovative techniques to previously unexami...on the "Slushball Earth" side of a decades-long sc...t. 29 Science Express. The lead author is Alison O...C College of Letters, Arts and Sciences. , Geologi...
...he longstanding challenges in the synthesis of pha...continuous regeneration of molecules called cofact...and environmentally friendly biocatalytic processe...y of Illinois at Urbana-Champaign and the Universi...d a microreactor that efficiently regenerates cofa...
...oming paper in the international, open-access jour...n yet between a newly identified virus and the ped.... Following their recent description of the corona...uggest this is one of the most frequently detected...infections (LRTIs). These infections are estimated...
Other Biology News:Study casts doubt on 'Snowball Earth' theory 2Microreactor efficiently regenerates cofactors for biocatalysis 2A novel virus for croup 2
...nes ,High Quality, Functionally-Validated, Ion Cha... having a critical role in nerve and muscle functi...NS and the heart. Drugs that modulate ion channels... as neuropathic pain, cardiac arrhythmia, hyperten...
Mouse Anti-Human TTC3 Monoclonal Antibody, Unconjugated, Clone 2D10 from Abnova Corporation
Mouse Anti-Human DENR Monoclonal Antibody, Unconjugated, Clone 1H3 from Abnova Corporation
Mouse Anti-Human CRKRS Monoclonal Antibody, Unconjugated, Clone 3C1 from Abnova Corporation
Biology Products: